Laekna (HKSE:02105) Debt-to-Equity : 0.07 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Laekna Debt-to-Equity?

Laekna's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$56.13 Mil. Laekna's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$5.54 Mil. Laekna's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$879.37 Mil. Laekna's debt to equity for the quarter that ended in Dec. 2023 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Laekna's Debt-to-Equity or its related term are showing as below:

HKSE:02105' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.03 Med: -0.02 Max: 0.07
Current: 0.07

During the past 3 years, the highest Debt-to-Equity Ratio of Laekna was 0.07. The lowest was -0.03. And the median was -0.02.

HKSE:02105's Debt-to-Equity is ranked better than
65.73% of 1065 companies
in the Biotechnology industry
Industry Median: 0.14 vs HKSE:02105: 0.07

Laekna Debt-to-Equity Historical Data

The historical data trend for Laekna's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laekna Debt-to-Equity Chart

Laekna Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Equity

-0.03

-0.02

0.07

Laekna Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	-0.03	N/A	-0.02	0.05	0.07

Competitive Comparison of Laekna's Debt-to-Equity

For the Biotechnology subindustry, Laekna's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laekna's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laekna's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Laekna's Debt-to-Equity falls into.

Laekna Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Laekna's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(56.129	+	5.544)	/	879.368
	=	0.07

Laekna's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(56.129	+	5.544)	/	879.368
	=	0.07

Laekna (HKSE:02105) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Laekna Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Laekna's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Laekna (HKSE:02105) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laekna Inc (HKSE:02105) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 987, Cailun Road, 5th Floor, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.laekna.com

Laekna Inc is a science-driven, clinical-stage biotechnology company. The company has established a comprehensive R&D infrastructure to accelerate the development of molecules from discovery to registrational trials. It has initiated one clinical trial and another five clinical trials for its Core Products LAE002 and LAE001. Among these six clinical trials, three multi-regional clinical trials (MRCTs) are designed to address medical needs in the standard of care (SOC)-resistant cancers. Laekna has two Core Products and 14 other pipeline product candidates. Core Product LAE002 is an adenosine triphosphate (ATP) competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, breast cancer and PD-1/PD-L1 drug-resistant solid tumors.

Executives

Gp Healthcare Capital, Inc.	2101 Beneficial owner
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Liu Zeng	2201 Interest of corporation controlled by you
Zhong Yi Ning Bo Sheng Tai Yuan Kong Gu Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Yao Shang Yan Chuang Si Mu Ji Jin Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Yao Shang Yan Chuang Shou Ren Gu Quan Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Yan Chuang Hou De Tou Zi Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Chun Lin Xin Xi Zi Xun Zhong Xin You Xian He Huo	2201 Interest of corporation controlled by you
Bei Jing An Long Chuang Ye Tou Zi Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you
Liu Ying	2201 Interest of corporation controlled by you
Guo Tou Zhao Shang Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin Er Qi You Xian He Huo	2101 Beneficial owner
Yu Yao Yang Ming Gu Quan Tou Zi Ji Jin You Xian Gong Si	2101 Beneficial owner
Futu Trustee Limited	2301 Trustee

Laekna (HKSE:02105) Headlines

No Headlines